Clinically, low levels of ceruloplasmin are the primary hallmark of Wilson disease, a genetic disorder leading to toxic copper accumulation in the brain and liver. Conversely, because ceruloplasmin is an acute-phase reactant, elevated levels are often observed during pregnancy, oral contraceptive use, or chronic inflammatory states such as rheumatoid arthritis and certain malignancies. Laboratory Methodology
Ceruloplasmin is a vital ferroxidase enzyme synthesized primarily in the liver. It carries about 95% of the copper found in human plasma. Measuring its levels is a cornerstone of clinical diagnostics, particularly for identifying Wilson disease and monitoring systemic inflammation. This essay explores the clinical significance, laboratory methodologies, and diagnostic utility of quantifying human serum ceruloplasmin. Biological and Clinical Significance
Ceruloplasmin plays a dual role in human physiology. As a transport protein, it regulates the distribution of copper throughout the body. More critically, its ferroxidase activity facilitates the oxidation of ferrous iron (Fe2+) to ferric iron (Fe3+). This conversion is essential for loading iron onto transferrin, allowing for safe transport through the bloodstream.
To help you find the specific or technical data you need, could you tell me:
Accurate measurement requires careful interpretation. One major complication is the presence of "aceruloplasminemia," where the protein is synthesized without its copper core. Immunological tests may detect this inactive protein and report a "normal" result, whereas an oxidase assay would correctly identify a lack of functional activity. Furthermore, because inflammation spikes ceruloplasmin levels, a patient with Wilson disease and a concurrent infection might show a "falsely normal" level, masking the underlying deficiency. Conclusion
